CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Pharmathen
    Pharmathen logo

    Pharmathen

    CDMO
    Greece
    https://www.pharmathen.com/

    Is this your company? Claim this profile

    Drug Substance
    Drug Product
    Analytical & Bioanalytical Services
    Regulatory, Tech Transfer & Support Services
    Advanced Modalities
    Excipients & Specialty Ingredients
    Company Overview

    About

    Pharmathen is a Greek research-centred CDMO specializing in complex drug delivery and formulation development. Founded in 1969 and acquired by Partners Group for $1.89 billion, the company operates two state-of-the-art manufacturing facilities: Rodopi (FDA-approved, 15,300 m2, capacity 3.3 billion tablets, 1.2 billion capsules, 175 million blisters, 4 million sterile syringes/vials) and Pallini/Attica (4,000 m2, 800 million tablets/capsules, 1.5 million sterile vials, 6 million ampoules). Pharmathen has also acquired CBL Patras. Key technology platforms include Long Acting Injectables (biodegradable microparticles, nanosuspensions, self-assembled nanogel systems), modified release oral formulations, preservative-free ophthalmic formulations, and solubility/permeability enhancement technologies.

    Key Expertise

    Long Acting Injectables (LAI), modified release oral formulations, preservative-free ophthalmic formulations, nanosuspension technology, complex drug delivery systems, lyophilization

    Therapeutic Areas

    Oncology
    CNS (Central Nervous System)
    Ophthalmology
    Allergy
    Psychiatry
    Quick Facts
    HQ:Greece
    Capabilities & Services

    Core Capabilities

    • Small Molecule Drug Product
    • Oral Solid Dose
    • Formulation Development

    Dosage Forms

    Oral Solid Dose
    Sterile Injectable
    Lyophilized (Freeze-Dried)
    Prefilled Syringe

    Production Scales

    Clinical
    Commercial Scale
    Large Scale (Metric Ton+)

    Annual Capacity

    Large Commercial (> 10,000 kg/year)

    Markets Served

    Europe
    Manufacturing Facilities

    2 sites worldwide

    Pharmathen - Greece Facility

    Greece
    View on Map

    Site Capabilities

    3 capabilities
    Quality Control
    Stability Testing
    Method Development

    Pharmathen - Netherlands Facility

    Netherlands
    View on Map

    Site Capabilities

    3 capabilities
    Quality Control
    Stability Testing
    Method Development
    Certifications

    FDA Registration

    U.S. Food and Drug Administration

    EMA GMP Certificate

    European Medicines Agency
    Request an Introduction

    Please log in to contact this provider.

    Key facts about Pharmathen

    • Pharmathen is headquartered in Greece.
    • Pharmathen has 2 manufacturing sites listed on CDMO Hub, in Greece and the Netherlands.
    • Pharmathen's capabilities include Small Molecule Drug Product, Oral Solid Dose and Formulation Development.

    Find CDMOs like Pharmathen

    Directory pages this company appears in, each with the full list of matching manufacturers.

    Small Molecule Drug Product CDMOsOral Solid Dose CDMOsFormulation Development CDMOsOral Solid Dose CDMOsSterile Injectable CDMOsLyophilized (Freeze-Dried) CDMOsPrefilled Syringe CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA